Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07737977) titled 'Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients' on July 27.

Study Type: Observational

Primary Sponsor: University Hospital, Montpellier

Condition: ALS (Amyotrophic Lateral Sclerosis)

Intervention: Other: peripheral venous blood collection

Recruitment Status: Not recruiting

Date of First Enrollment: August 2026

Target Sample Size: 200

Countries of Recruitment: France Spain France Spain

To know more, visit https://clinicaltrials.gov/study/NCT07737977

Disclaimer: Curated by HT Syndication....